[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. 2939 Introduced in Senate (IS)]

<DOC>






118th CONGRESS
  1st Session
                                S. 2939

To amend title XVIII of the Social Security Act to require reporting on 
    enforcement and oversight of pharmacy access requirements under 
                            Medicare part D.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

           September 27 (legislative day, September 22), 2023

 Mrs. Blackburn (for herself and Ms. Hassan) introduced the following 
  bill; which was read twice and referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL


 
To amend title XVIII of the Social Security Act to require reporting on 
    enforcement and oversight of pharmacy access requirements under 
                            Medicare part D.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Pharmacy Access Oversight and 
Reporting Act''.

SEC. 2. REPORTING ON ENFORCEMENT AND OVERSIGHT OF PHARMACY ACCESS 
              REQUIREMENTS.

    Section 1860D-42 of the Social Security Act (42 U.S.C. 1395w-152) 
is amended by adding at the end the following new subsection:
    ``(e) Biennial Report on Enforcement and Oversight of Pharmacy 
Access Requirements.--
            ``(1) In general.--Not later than 2 years after the date of 
        enactment of this subsection, and at least once every 2 years 
        thereafter, the Secretary shall publish a report on enforcement 
        and oversight actions and activities undertaken by the 
        Secretary with respect to the requirements under section 1860D-
        4(b)(1).
            ``(2) Limitation.--A report under paragraph (1) shall not 
        disclose--
                    ``(A) identifiable information about individuals or 
                entities unless such information is otherwise publicly 
                available; or
                    ``(B) trade secrets with respect to any 
                entities.''.
                                 <all>